165 related articles for article (PubMed ID: 2114763)
41. Gadopentetate dimeglumine: observations on the clinical research process.
Kieffer SA
Radiology; 1990 Jan; 174(1):7-8. PubMed ID: 2403685
[No Abstract] [Full Text] [Related]
42. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine.
Pediconi F; Catalano C; Occhiato R; Venditti F; Fraioli F; Napoli A; Kirchin MA; Passariello R
Radiology; 2005 Oct; 237(1):45-56. PubMed ID: 16126926
[TBL] [Abstract][Full Text] [Related]
43. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns.
Strouse PJ; Prince MR; Chenevert TL
Radiology; 1996 Dec; 201(3):809-16. PubMed ID: 8939236
[TBL] [Abstract][Full Text] [Related]
44. Spinal lesions: quantitative and qualitative temporal evolution of gadopentetate dimeglumine enhancement in MR imaging.
Sze G; Bravo S; Krol G
Radiology; 1989 Mar; 170(3 Pt 1):849-56. PubMed ID: 2916042
[TBL] [Abstract][Full Text] [Related]
45. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
Knopp MV; Runge VM; Essig M; Hartman M; Jansen O; Kirchin MA; Moeller A; Seeberg AH; Lodemann KP
Radiology; 2004 Jan; 230(1):55-64. PubMed ID: 14695387
[TBL] [Abstract][Full Text] [Related]
46. MR diagnosis of paraganglioma of the head and neck: value of contrast enhancement.
van Gils AP; van den Berg R; Falke TH; Bloem JL; Prins HJ; Dillon EH; van der Mey AG; Pauwels EK
AJR Am J Roentgenol; 1994 Jan; 162(1):147-53. PubMed ID: 8273654
[TBL] [Abstract][Full Text] [Related]
47. MR imaging in retinoblastoma.
Barkhof F; Smeets M; van der Valk P; Tan KE; Hoogenraad F; Peeters J; Valk J
Eur Radiol; 1997; 7(5):726-31. PubMed ID: 9166573
[TBL] [Abstract][Full Text] [Related]
48. Persistent and recurrent hyperparathyroidism: assessment with gadopentetate dimeglumine-enhanced MR imaging.
Seelos KC; DeMarco R; Clark OH; Higgins CB
Radiology; 1990 Nov; 177(2):373-8. PubMed ID: 2217771
[TBL] [Abstract][Full Text] [Related]
49. Intraorbital optic nerve and experimental optic neuritis. Correlation of fat suppression magnetic resonance imaging and electron microscopy.
Guy J; Fitzsimmons J; Ellis EA; Beck B; Mancuso A
Ophthalmology; 1992 May; 99(5):720-5. PubMed ID: 1594217
[TBL] [Abstract][Full Text] [Related]
50. Dynamic contrast-enhanced breath-hold MR imaging of thoracic malignancy using cardiac compensation.
Low RN; Sigeti JS; Song SY; Shimakawa A; Pelc NJ
J Magn Reson Imaging; 1996; 6(4):625-31. PubMed ID: 8835956
[TBL] [Abstract][Full Text] [Related]
51. MR imaging of spondylitis with gadopentetate dimeglumine enhancement.
Demaerel P; van Ongeval C; Wilms G; Lateur L; Baert AL
J Neuroradiol; 1994 Dec; 21(4):245-54. PubMed ID: 7884486
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of gadolinium administration in magnetic resonance imaging screening of patients with complex partial seizures and results of a normal neurologic examination.
Sanders WP; Silbergleit R; Spickler EM; Barkley GL; Mehta BA
Invest Radiol; 1995 Nov; 30(11):634-7. PubMed ID: 8557503
[TBL] [Abstract][Full Text] [Related]
53. Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images.
Sherman JL; Stern BJ
AJR Am J Roentgenol; 1990 Dec; 155(6):1293-301. PubMed ID: 2122683
[TBL] [Abstract][Full Text] [Related]
54. Lumbosacral spine: early and delayed MR imaging after administration of an expanded dose of gadopentetate dimeglumine in healthy, asymptomatic subjects.
Jinkins JR; Rauch RA; Gee GT; Bazan C; Xiong L; Kashanian FK; Hanna EP
Radiology; 1995 Oct; 197(1):247-51. PubMed ID: 7568831
[TBL] [Abstract][Full Text] [Related]
55. Morton neuroma: evaluation with MR imaging performed with contrast enhancement and fat suppression.
Terk MR; Kwong PK; Suthar M; Horvath BC; Colletti PM
Radiology; 1993 Oct; 189(1):239-41. PubMed ID: 8372200
[TBL] [Abstract][Full Text] [Related]
56. Gadopentetate dimeglumine-enhanced MR of the brain: clinical utility and safety in patients younger than two years of age.
Eldevik OP; Brunberg JA
AJNR Am J Neuroradiol; 1994 Jun; 15(6):1001-8. PubMed ID: 8073967
[TBL] [Abstract][Full Text] [Related]
57. Contrast-enhanced gradient-echo MR imaging of the head and neck: experimental and clinical assessment.
Mihara F; Gupta KL; Joslyn JN
Radiat Med; 1994; 12(4):147-51. PubMed ID: 7809407
[TBL] [Abstract][Full Text] [Related]
58. Spinal cord pial metastases: MR imaging with gadopentetate dimeglumine.
Lim V; Sobel DF; Zyroff J
AJR Am J Roentgenol; 1990 Nov; 155(5):1077-84. PubMed ID: 2120938
[TBL] [Abstract][Full Text] [Related]
59. Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T.
Chang KH; Ra DG; Han MH; Cha SH; Kim HD; Han MC
AJNR Am J Neuroradiol; 1994 Sep; 15(8):1413-9; discussion 1420-3. PubMed ID: 7985558
[TBL] [Abstract][Full Text] [Related]
60. CNS sarcoidosis: evaluation with contrast-enhanced MR imaging.
Seltzer S; Mark AS; Atlas SW
AJNR Am J Neuroradiol; 1991; 12(6):1227-33. PubMed ID: 1763760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
